Download PDF
1 / Pages

Other users also viewed these articles

New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy Sérgio Maltês; Luis Rocha Lopes;
Rev Port Cardiol. 2020;39:99-109
Beware of regression of electrocardiographic abnormalities on detraining ¿ It may not always mean `athlete's heart¿ José Pedro Marques; António Freitas; João Abecasis;
Rev Port Cardiol. 2021;40:801.e1-6
Impact of the creation of specialized units for patients with hypertrophic cardiomyopathy Martín Negreira-Caamaño; Jesús Piqueras-Flores; Inmaculada Vivo-Ortega; María Arántzazu-González-Marín; Manuel Muñoz-García; Alberto Jiménez-Lozano;
Rev Port Cardiol. 2021;40:221-3